Inovalon Buys Ability Network for $1.2 Billion
Healthcare IT company Ability Network has been acquired by Inovalon Holdings Inc. (NASDAQ: INOV) for $1.1 billion in cash and $100 million in restricted shares of Inovalon’s Class A stock. Ability Network, a portfolio company of Summit Partners, makes cloud-based programs, which connect healthcare providers and insurers. It is used at over 44,000 acute, post-acute and ambulatory point-of-care provider facilities. It generates approximately $130 million in revenue. Inovalon provides advanced cloud-based data analytics and data-driven intervention platforms to the U.S. healthcare industry. On a trailing 12-month basis, it generated revenue of $449.4 million, EBITDA of $75.9 million and... Read More »Deal of the Week: R1RCM/Intermedix Corporation
R1 RCM Inc. (NASDAQ: RCM), a provider of revenue cycle management services to healthcare providers, announced its acquisition of Intermedix Corporation, a portfolio company of Thomas H. Lee Partners, on February 26. Intermedix is a global leader in data analytics and cloud-based technology that delivers best-in-class revenue cycle management (RCM), practice management and emergency management solutions. It supports more than 500,000 emergency preparedness and response incidents worldwide and enables more than 15,000 health care providers to focus on patient care. The acquisition by R1 RCM includes Intermedix’s healthcare division, which is comprised of its physician and EMS RCM... Read More »
Roche Deal for Flatiron Health Builds its Oncology Muscle
Roche (SIX: RO) couldn’t let a good startup slip away. The Swiss drug maker announced it will pay $1.9 billion to keep New York City-based Flatiron Health, Inc. from going public. When it was founded in 2012, Flatiron’s goal was to gather and analyze data on cancer treatments and sells software based on those insights to help researchers develop drugs more quickly, and with more targeted precision. Toward that end, the company produced an oncology-specific electronic health record (EHR). It currently partners with more than 265 community cancer clinics, six major academic research centers and 14 out of the top 15 therapeutic oncology companies. Roche already holds a 12.6% stake... Read More »
